Purchase Order 75F40124P00387
Award Date
8/22/24
Potential Completion Date
8/29/25
Potential Value
$192K
Federal Agency
Food and Drug Administration
Awardee
Aneon Brillient, LLC
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...
This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
This award represents a 1-year, $190,357.34 time and materials contract for information technology professional services awarded by the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture. The contract supports the Office of Pharmaceutical Quality within CDER. As an 8(a) sole source award, this contract leverages the SBA's business development program to provide specialized IT services to the FDA....
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a Small Business Administration (SBA) certified 8(a) joint venture, for $326,304.48. The contract provides shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract is set aside for 8(a) small businesses and has a performance period ending on September 29, 2026....
This is a $1,479,584.76 sole-source 8(a) contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned and small disadvantaged business. The contract is for Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). As an 8(a) certified company, Aneon Brillient is able to obtain this single-award, labor-hour contract directly from the FDA without a competitive process. The contract has an...
This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, to provide administrative staffing services for the Center for Drug Evaluation and Research (CDER). The 12-month base contract with a 1-year option period has a ceiling value of $186,092.22 and is a labor-hour type contract. This award demonstrates Aneon Brillient's ongoing support to the FDA, as evidenced by their prior 8(a) sole source...
The Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a Blanket Purchase Agreement (BPA) call to Brillient Corporation, a Minority Owned Business, to obtain the services of a Quality Assurance Specialist III to act as a lead quality management specialist. The contract, valued at $167,166.20, has a period of performance through July 6, 2021 and was issued under the Professional Services Schedule (PSS) contract vehicle. Brillient, as the prime contractor,...
This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Brillient Corporation, a minority-owned small business. The contract, valued at $139,863.45, is for administrative support services and is a call order under the FDA's Professional and Technical Services Blanket Purchase Agreement (BPA). The contract has an ultimate completion date of August 26, 2024. Brillient Corporation is an experienced federal contractor, having been awarded numerous...
This is a BPA (Blanket Purchase Agreement) call under the GSA Professional Services Schedule (PSS) contract, awarded by the Food and Drug Administration (FDA) to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The contract provides $90,358.58 in administrative support services for the FDA's Office of Regulatory Affairs (ORA) and Office of Translational Engineering and Development (OTED). The contract has an ultimate completion date of June 12, 2020 and was awarded...